ISA Pharmaceuticals Overview
- Year Founded
-
2004
- Status
-
Out of Business
- Employees
-
21
- Latest Deal Type
-
Liquidation
ISA Pharmaceuticals General Information
Description
Developer of synthetic therapeutic vaccines designed to provide treatment for cancer. The company's vaccines are based on proprietary synthetic long peptide technologies that provide treatment for cancer and persistent viral infections, enabling patients with treatment to have a likelihood of success.
Contact Information
Website
www.isa-pharma.comCorporate Office
- Leiden Bio Science Park
- De Limes 7
- 2342 DH Oegstgeest
- Netherlands
Corporate Office
- Leiden Bio Science Park
- De Limes 7
- 2342 DH Oegstgeest
- Netherlands
ISA Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Bankruptcy: Liquidation | 18-Jul-2024 | Completed | Bankruptcy: Liquidation | |||
| 9. Secondary Transaction - Private | Completed | Clinical Trials - Phase 2 | ||||
| 8. Later Stage VC | 15-Dec-2022 | Completed | Clinical Trials - Phase 2 | |||
| 7. Later Stage VC (Series B) | 06-Jul-2021 | Completed | Clinical Trials - Phase 2 | |||
| 6. Later Stage VC | 17-Jun-2020 | Completed | Clinical Trials - Phase 2 | |||
| 5. Debt - General | 28-Jun-2019 | Completed | Clinical Trials - General | |||
| 4. Secondary Transaction - Private | Completed | Clinical Trials - General | ||||
| 3. Later Stage VC | 07-Jan-2013 | Completed | Clinical Trials - General | |||
| 2. Grant | $27.3M | $14.8M | Completed | Startup | ||
| 1. Early Stage VC (Series A) | 01-Jan-2004 | $14.8M | $14.8M | Completed | Startup |
ISA Pharmaceuticals Comparisons
Industry
Financing
Details
ISA Pharmaceuticals Competitors (7)
One of ISA Pharmaceuticals’s 7 competitors is Virometix, a Venture Capital-Backed company based in Schlieren, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Virometix | Venture Capital-Backed | Schlieren, Switzerland | ||||
| Inotrem | Venture Capital-Backed | Paris, France | ||||
| F-Star Therapeutics | Formerly VC-backed | Cambridge, United Kingdom | ||||
| Scancell Holdings | Formerly VC-backed | Oxford, United Kingdom | ||||
| Theravectys | Venture Capital-Backed | Paris, France |
ISA Pharmaceuticals Patents
ISA Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025008085-A1 | Immunotherapy for the treatment of prame-expressing cancers | Inactive | 05-Jul-2023 | ||
| WO-2024223299-A2 | Methods of treating cancer by administering immunogenic compositions and a pd-1 inhibitor | Inactive | 26-Apr-2023 | ||
| WO-2024223299-A3 | Methods of treating cancer by administering immunogenic compositions and a pd-1 inhibitor | Inactive | 26-Apr-2023 | ||
| WO-2024149888-A1 | Improved lipopeptide quantification | Inactive | 12-Jan-2023 | ||
| WO-2024079311-A1 | Modified long peptides suitable for use in immunisation | Inactive | 13-Oct-2022 | A61K39/12 |
ISA Pharmaceuticals Signals
ISA Pharmaceuticals FAQs
-
When was ISA Pharmaceuticals founded?
ISA Pharmaceuticals was founded in 2004.
-
Where is ISA Pharmaceuticals headquartered?
ISA Pharmaceuticals is headquartered in Oegstgeest, Netherlands.
-
What is the size of ISA Pharmaceuticals?
ISA Pharmaceuticals has 21 total employees.
-
What industry is ISA Pharmaceuticals in?
ISA Pharmaceuticals’s primary industry is Drug Discovery.
-
Is ISA Pharmaceuticals a private or public company?
ISA Pharmaceuticals is a Private company.
-
What is ISA Pharmaceuticals’s current revenue?
The current revenue for ISA Pharmaceuticals is .
-
How much funding has ISA Pharmaceuticals raised over time?
ISA Pharmaceuticals has raised $84M.
-
Who are ISA Pharmaceuticals’s competitors?
Virometix, Inotrem, F-Star Therapeutics, Scancell Holdings, and Theravectys are some of the 7 competitors of ISA Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process